Purple Charas is a modern hybrid cannabis strain derived from the Charas-Plant. As a contemporary genetic variety, it has been engineered to provide high yields while maintaining a moderate degree of difficulty for cultivators. Those growing the plant can expect a flowering cycle of approximately 50 days, with the strain proving adaptable to both indoor and outdoor cultivation environments. Its genetic significance is solidified by its role as a parent to the notable offspring, Kush Coma.

The phytochemical composition of Purple Charas is defined by a dense terpene profile led by myrcene, terpinolene, and caryophyllene, followed by limonene, ocimene, and linalool. This complex arrangement continues with humulene, pinene, beta-pinene, bisabolol, guaiol, alpha-terpinene, nerolidol, and finally camphene. This broad array of terpenes contributes to the cultivar's specific sensory characteristics, providing a nuanced aromatic and flavor experience that reflects its intricate chemical hierarchy.

As a THC-dominant variety, Purple Charas induces effects primarily characterized by feelings of relaxation, happiness, and an uplifted mood. Due to these specific psychoactive properties, the strain is frequently selected for its potential to address concerns related to stress, pain, and sleep. Given its reliable production and well-documented cannabinoid profile, the cultivar remains a functional option for both medicinal use cases and those seeking a predictable, mood-elevating experience.